Current Options for the Treatment of Neoplastic Meningitis

Overview

Journal J Neurooncol

Publisher Springer

Date 2002 Nov 6

PMID 12416549

Citations 6

Authors

Ilkcan Cokgor

Allan H Friedman

Henry S Friedman

Affiliations

Soon will be listed here.

Abstract

Neoplastic meningitis, which is the diffuse involvement of the leptomeninges by infiltrating cancer cells, may be caused by many systemic tumors. The treatment options for neoplastic meningitis disease remain unsatisfactory. In this review article, we discuss the pathogenesis and cytology of neoplastic meningitis and the options for treatment, including intrathecal chemotherapy, systemic chemotherapy, and newer agents such as cytokines and monoclonal antibodies.

Citing Articles

Meningeal Carcinomatosis Presenting with Bilateral Loss of Vision.

Ohki R, Kunimi H, Hosoda S, Okamoto T, Tsuneyoshi Y, Hayashi S Neuroophthalmology. 2024; 48(3):169-175.

PMID: 38756339 PMC: 11095578. DOI: 10.1080/01658107.2023.2290537.

Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.

Le Rhun E, Taillibert S, Chamberlain M Surg Neurol Int. 2013; 4(Suppl 4):S265-88.

PMID: 23717798 PMC: 3656567. DOI: 10.4103/2152-7806.111304.

Objective response with lapatinib in patients with meningitis carcinomatosa derived from HER2/HER1-negative breast cancer.

Onishi H, Morisaki T, Nakafusa Y, Nakashima Y, Yokohata K, Katano M Int J Clin Oncol. 2011; 16(6):718-21.

PMID: 21327450 DOI: 10.1007/s10147-011-0195-5.

Carcinomatous meningitis from urachal carcinoma: the first reported case.

McClelland 3rd S, Garcia R, Monaco S, Goldman J, Olson T, Kim G J Neurooncol. 2005; 76(2):171-4.

PMID: 16307300 DOI: 10.1007/s11060-005-4815-7.

Leptomeningeal metastases from solid malignancy: a review.

Taillibert S, Laigle-Donadey F, Chodkiewicz C, Sanson M, Hoang-Xuan K, Delattre J J Neurooncol. 2005; 75(1):85-99.

PMID: 16215819 DOI: 10.1007/s11060-004-8101-x.

References

Klein P, HALEY E, Wooten G, Vandenberg S . Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastases. Arch Neurol. 1989; 46(10):1149-52. DOI: 10.1001/archneur.1989.00520460145030. View

Kim S, Chatelut E, Kim J, Howell S, Cates C, Kormanik P . Extended CSF cytarabine exposure following intrathecal administration of DTC 101. J Clin Oncol. 1993; 11(11):2186-93. DOI: 10.1200/JCO.1993.11.11.2186. View

Petit T, Dufour P, Korganov A, Maloisel F, Oberling F . Continuous intrathecal perfusion of methotrexate for carcinomatous meningitis with pharmacokinetic studies: two case studies. Clin Oncol (R Coll Radiol). 1997; 9(3):189-90. DOI: 10.1016/s0936-6555(97)80080-5. View

Hitchins R, Bell D, Woods R, LEVI J . A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol. 1987; 5(10):1655-62. DOI: 10.1200/JCO.1987.5.10.1655. View

Amer M, Al-Sarraf M, Baker L, VAITKEVICIUS V . Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer. 1978; 42(2):660-8. DOI: 10.1002/1097-0142(197808)42:2<660::aid-cncr2820420237>3.0.co;2-e. View

GALTON D . Myleran in chronic myeloid leukaemia; results of treatment. Lancet. 1953; 264(6753):208-13. DOI: 10.1016/s0140-6736(53)90885-x. View

Liaw C, Ng K, Huang J, Wang C, Kiu M, Lai G . Meningeal carcinomatosis from solid tumors: clinical analysis of 42 cases. J Formos Med Assoc. 1992; 91(3):299-303. View

Sculier J . Treatment of meningeal carcinomatosis. Cancer Treat Rev. 1985; 12(2):95-104. DOI: 10.1016/0305-7372(85)90002-7. View

MELLETT L . Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous system. Cancer Treat Rep. 1977; 61(4):527-31. View

10.

Adamson P, Balis F, Arndt C, Holcenberg J, Narang P, Murphy R . Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study. Cancer Res. 1991; 51(22):6079-83. View

11.

Coakham H, Kemshead J . Treatment of neoplastic meningitis by targeted radiation using (131)I-radiolabelled monoclonal antibodies. Results of responses and long term follow-up in 40 patients. J Neurooncol. 1998; 38(2-3):225-32. DOI: 10.1023/a:1005996606073. View

12.

Grossman S, Finkelstein D, Ruckdeschel J, Trump D, Moynihan T, Ettinger D . Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol. 1993; 11(3):561-9. DOI: 10.1200/JCO.1993.11.3.561. View

13.

Jayson G, Howell A, Harris M, Morgenstern G, Chang J, Ryder W . Carcinomatous meningitis in patients with breast cancer. An aggressive disease variant. Cancer. 1994; 74(12):3135-41. DOI: 10.1002/1097-0142(19941215)74:12<3135::aid-cncr2820741212>3.0.co;2-8. View

14.

Boogerd W, vd Sande J, MOFFIE D . Acute fever and delayed leukoencephalopathy following low dose intraventricular methotrexate. J Neurol Neurosurg Psychiatry. 1988; 51(10):1277-83. PMC: 1032916. DOI: 10.1136/jnnp.51.10.1277. View

15.

Aaron R, ELION G, COLVIN O, Graham M, Keir S, Bigner D . Busulfan therapy of central nervous system xenografts in athymic mice. Cancer Chemother Pharmacol. 1994; 35(2):127-31. DOI: 10.1007/BF00686634. View

16.

Giannone L, Greco F, Hainsworth J . Combination intraventricular chemotherapy for meningeal neoplasia. J Clin Oncol. 1986; 4(1):68-73. DOI: 10.1200/JCO.1986.4.1.68. View

17.

Shapiro W, Young D, Mehta B . Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med. 1975; 293(4):161-6. DOI: 10.1056/NEJM197507242930402. View

18.

Ongerboer de Visser B, Somers R, Nooyen W, van Heerde P, Hart A, McVie J . Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology. 1983; 33(12):1565-72. DOI: 10.1212/wnl.33.12.1565. View

19.

Siegal T, Lossos A, Pfeffer M . Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology. 1994; 44(8):1463-9. DOI: 10.1212/wnl.44.8.1463. View

20.

Weller M, Sommer N, Stevens A, Wietholter H . Increased intrathecal synthesis of fibronectin in bacterial and carcinomatous meningitis. Acta Neurol Scand. 1990; 82(2):138-42. DOI: 10.1111/j.1600-0404.1990.tb01604.x. View